Patents by Inventor Börje Haraldsson

Börje Haraldsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD40 antibodies for use in prevention of graft rejection
    Patent number: 11780927
    Abstract: The disclosure relates to methods, treatment regimens, uses, kits and therapies for preventing graft rejection in solid organ transplantation, by employing anti-CD40 antibodies.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: October 10, 2023
    Assignee: NOVARTIS AG
    Inventors: Pascal Espie, Boerje Haraldsson, James Rush
  • Uses of piperidinyl-indole derivatives
    Patent number: 11723901
    Abstract: The present invention relates to the novel use of certain piperidinyl-indole derivatives in the treatment of patients suffering from renal diseases or disorders, and in particular for the treatment of patients suffering from C3G (C3 glomerulopathy) and IgAN (IgA nephropathy).
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: August 15, 2023
    Assignee: Novartis AG
    Inventors: Jörg Eder, Richard Alexander Harrison, Boerje Haraldsson, Anna Svenja Schubart
  • SOLUBILIZED APYRASES, METHODS AND USE
    Publication number: 20220356455
    Abstract: The invention relates to design and therapeutic use of solubilized apyrase polypeptides, pharmaceuticals compositions, therapeutic uses and methods useful for preventing and treating tissue damage.
    Type: Application
    Filed: July 17, 2019
    Publication date: November 10, 2022
    Inventors: Agostino CIRILLO, Hilmar EBERSBACH, Boerje HARALDSSON, Thomas HUBER, Guido JUNGE, Regina LINK, Max WARNCKE, Chao ZOU
  • NOVEL USES OF PIPERIDINYL-INDOLE DERIVATIVES
    Publication number: 20220152011
    Abstract: The present invention relates to the novel use of certain piperidinyl-indole derivatives in the treatment of patients suffering from renal diseases or disorders, and in particular for the treatment of patients suffering from C3G (C3 glomerulopathy) and IgAN (IgA nephropathy).
    Type: Application
    Filed: January 31, 2022
    Publication date: May 19, 2022
    Inventors: Jorg EDER, Richard Alexander HARRISON, Boerje HARALDSSON, Anna Svenja WELLENSIEK SCHUBART
  • ANTI-CD40 ANTIBODIES FOR USE IN PREVENTION OF GRAFT REJECTION
    Publication number: 20210079107
    Abstract: The disclosure relates to methods, treatment regimens, uses, kits and therapies for preventing graft rejection in solid organ transplantation, by employing anti-CD40 antibodies.
    Type: Application
    Filed: April 11, 2019
    Publication date: March 18, 2021
    Inventors: Pascal ESPIE, Boerje HARALDSSON, James RUSH
  • Treatment of renal cell carcinoma
    Patent number: 8349823
    Abstract: Methods are provided of treating renal cancer by administration of certain 3,3?,4,4?-tetrahydroxy-2,2?-bipyridine-N,N?-dioxide compounds, especially 3,3?,4,4?-tetrahydroxy-2,2?-bipyridine-N,N?-dioxide (Orellanine), using particular administration protocols and dosing regimens, as well as pharmaceutical compositions suitable for use in the treatment methods that are provided.
    Type: Grant
    Filed: September 21, 2011
    Date of Patent: January 8, 2013
    Assignee: Oncorena AB
    Inventors: Börje Haraldsson, Ulf Nilsson, Lisa Buvall, Jenny Nyström
  • Treatment of renal cell carcinoma
    Publication number: 20120077846
    Abstract: Methods are provided of treating renal cancer by administration of certain 3,3?,4,4?-tetrahydroxy-2,2?-bipyridine-N,N?-dioxide compounds, especially 3,3?,4,4?-tetrahydroxy-2,2?-bipyridine-N,N?-dioxide (Orellanine), using particular administration protocols and dosing regimens, as well as pharmaceutical compositions suitable for use in the treatment methods that are provided.
    Type: Application
    Filed: September 21, 2011
    Publication date: March 29, 2012
    Inventors: Börje Haraldsson, Ulf Nilsson, Lisa Buvall, Jenny Nyström
  • Treatment of renal cell carcinoma
    Patent number: 8053430
    Abstract: Methods are provided of treating renal cancer by administration of certain 3,3?,4,4?-tetrahydroxy-2,2?-bipyridine-N,N?-dioxide compounds, especially 3,3?,4,4?-tetrahydroxy-2,2?-bipyridine-N,N?-dioxide (Orellanine), using particular administration protocols and dosing regimens, as well as pharmaceutical compositions suitable for use in the treatment methods that are provided.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: November 8, 2011
    Inventors: Börje Haraldsson, Ulf Nilsson, Lisa Buvall, Jenny Nyström
  • Treatment of renal cell carcinoma
    Publication number: 20100152243
    Abstract: Methods are provided of treating renal cancer by administration of certain 3,3?,4,4?-tetrahydroxy-2,2?-bipyridine-N,N?-dioxide compounds, especially 3,3?,4,4?-tetrahydroxy-2,2?-bipyridine-N,N?-dioxide (Orellanine), using particular administration protocols and dosing regimens, as well as pharmaceutical compositions suitable for use in the treatment methods that are provided.
    Type: Application
    Filed: September 29, 2009
    Publication date: June 17, 2010
    Inventors: Börje Haraldsson, Ulf Nilsson, Lisa Buvall, Jenny Nyström
  • Method and apparatus for preventing protein loss with peritoneal dialysis
    Patent number: 6585682
    Abstract: Methods of peritoneal dialysis are disclosed including draining spent peritoneal dialysis solution from a patient to a drain bag, passing the spent peritoneal dialysis solution from the drain bag through a filter so as to separate a protein rich fraction and a protein lean fraction therefrom, and supplying the protein enriched fraction to the fresh peritoneal dialysis solution for supply to the patient. Apparatus for peritoneal dialysis is also disclosed.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: July 1, 2003
    Assignee: Gambro AB
    Inventors: Börje Haraldsson, Jan-Bertil Jeppsson, Bengt-Olov Thell